Home / Import refusals / 1FX-3853807-1/10002/2

FDA Import Refusal 1FX-3853807-1/10002/2 — CIPLA PHARMA LTD

CIPLA PHARMA LTD — FEI 3041524050

The FDA refused shipment 1FX-3853807-1/10002/2 from CIPLA PHARMA LTD (India) on Sep 25, 2026. The refused product falls under Drugs and Biologics — TADALAFIL. Cited charge: 75 This firm has 2 other import refusals on record.

Refusal Details

Date
Sep 25, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
66SDY51 TADALAFIL
Charges
75

Other import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.